 | • レポートコード：QAF27811 • 出版社/出版日：QYResearch / 2021年3月31日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のオピオイド薬市場について種類別（オキシコドン、ヒドロモルフォン、コデイン、フェンタニル、その他）、用途別（鎮痛、麻酔、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・オピオイド薬市場の概要 ・世界の主要地域別オピオイド薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のオピオイド薬市場規模2016-2021：種類別（オキシコドン、ヒドロモルフォン、コデイン、フェンタニル、その他） ・世界のオピオイド薬市場予測2012-2027：種類別（オキシコドン、ヒドロモルフォン、コデイン、フェンタニル、その他） ・世界のオピオイド薬市場規模2016-2021：用途別（鎮痛、麻酔、その他） ・世界のオピオイド薬市場予測2012-2027：用途別（鎮痛、麻酔、その他） ・オピオイド薬のアメリカ市場規模と予測2016-2021 ・オピオイド薬のヨーロッパ市場規模と予測2016-2021 ・オピオイド薬の中国市場規模と予測2016-2021 ・オピオイド薬の日本市場規模と予測2016-2021 ・オピオイド薬の東南アジア市場規模と予測2016-2021 ・オピオイド薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Teva、Purdue Pharma、Mallinckrodt、Amneal Pharma、Collegium、J&J、Endo、Pfizer、INSYS、Mylan、Hikma、Egalet） ・オピオイド薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・オピオイド薬の市場動向・機会・課題 ・調査の結論 |
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The classification of Opioids Drug includes Oxycodone, Hydromorphone, Codeine, Fentanyl and Other, and the revenue proportion of Oxycodone in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016.
Opioids Drug is widely used for Pain Relief, Anesthesia and Other. The most proportion of Opioids Drug is for Pain Relief, and the proportion in 2016 is about 66.5%.
North America is the largest supplier of Opioids Drug, with a production market share nearly 71% in 2016. Europe is the second largest supplier of Opioids Drug Media, enjoying production market share nearly 16% in 2016.
North America is the largest consumption place, with a consumption market share nearly 60.5 % in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
Market competition is not intense. Purdue Pharma, J&J, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Opioids Drug Market
The global Opioids Drug market was valued at US$ 10050 in 2020 and will reach US$ 9016.6 million by the end of 2027, growing at a CAGR of -1.8% during 2022-2027.
Global Opioids Drug Scope and Market Size
The global Opioids Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioids Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Others
Segment by Application
Pain Relief
Anesthesia
Others
The Opioids Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Opioids Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
1 Opioids Drug Market Overview
1.1 Opioids Drug Product Scope
1.2 Opioids Drug Segment by Type
1.2.1 Global Opioids Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Others
1.3 Opioids Drug Segment by Application
1.3.1 Global Opioids Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Opioids Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Opioids Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Opioids Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Opioids Drug Price Trends (2016-2027)
2 Opioids Drug Estimates and Forecasts by Region
2.1 Global Opioids Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Opioids Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Opioids Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Opioids Drug Revenue Market Share by Region (2016-2021)
2.3 Global Opioids Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Opioids Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Opioids Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Opioids Drug Estimates and Projections (2016-2027)
2.4.2 Europe Opioids Drug Estimates and Projections (2016-2027)
2.4.3 China Opioids Drug Estimates and Projections (2016-2027)
2.4.4 Japan Opioids Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Opioids Drug Estimates and Projections (2016-2027)
2.4.6 India Opioids Drug Estimates and Projections (2016-2027)
3 Global Opioids Drug Competition Landscape by Players
3.1 Global Top Opioids Drug Players by Sales (2016-2021)
3.2 Global Top Opioids Drug Players by Revenue (2016-2021)
3.3 Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids Drug as of 2020)
3.4 Global Opioids Drug Average Price by Company (2016-2021)
3.5 Manufacturers Opioids Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Opioids Drug Market Size by Type
4.1 Global Opioids Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Opioids Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Opioids Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Opioids Drug Price by Type (2016-2021)
4.2 Global Opioids Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Opioids Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Opioids Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Opioids Drug Price Forecast by Type (2022-2027)
5 Global Opioids Drug Market Size by Application
5.1 Global Opioids Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Opioids Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Opioids Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Opioids Drug Price by Application (2016-2021)
5.2 Global Opioids Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Opioids Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Opioids Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Opioids Drug Price Forecast by Application (2022-2027)
6 North America Opioids Drug Market Facts & Figures
6.1 North America Opioids Drug Sales by Company
6.1.1 North America Opioids Drug Sales by Company (2016-2021)
6.1.2 North America Opioids Drug Revenue by Company (2016-2021)
6.2 North America Opioids Drug Sales Breakdown by Type
6.2.1 North America Opioids Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Opioids Drug Sales Breakdown by Type (2022-2027)
6.3 North America Opioids Drug Sales Breakdown by Application
6.3.1 North America Opioids Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Opioids Drug Sales Breakdown by Application (2022-2027)
7 Europe Opioids Drug Market Facts & Figures
7.1 Europe Opioids Drug Sales by Company
7.1.1 Europe Opioids Drug Sales by Company (2016-2021)
7.1.2 Europe Opioids Drug Revenue by Company (2016-2021)
7.2 Europe Opioids Drug Sales Breakdown by Type
7.2.1 Europe Opioids Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Opioids Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Opioids Drug Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China Opioids Drug Market Facts & Figures
8.1 China Opioids Drug Sales by Company
8.1.1 China Opioids Drug Sales by Company (2016-2021)
8.1.2 China Opioids Drug Revenue by Company (2016-2021)
8.2 China Opioids Drug Sales Breakdown by Type
8.2.1 China Opioids Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Opioids Drug Sales Breakdown by Type (2022-2027)
8.3 China Opioids Drug Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Opioids Drug Market Facts & Figures
9.1 Japan Opioids Drug Sales by Company
9.1.1 Japan Opioids Drug Sales by Company (2016-2021)
9.1.2 Japan Opioids Drug Revenue by Company (2016-2021)
9.2 Japan Opioids Drug Sales Breakdown by Type
9.2.1 Japan Opioids Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Opioids Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Opioids Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Opioids Drug Market Facts & Figures
10.1 Southeast Asia Opioids Drug Sales by Company
10.1.1 Southeast Asia Opioids Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Opioids Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Opioids Drug Sales Breakdown by Type
10.2.1 Southeast Asia Opioids Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Opioids Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Opioids Drug Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)
11 India Opioids Drug Market Facts & Figures
11.1 India Opioids Drug Sales by Company
11.1.1 India Opioids Drug Sales by Company (2016-2021)
11.1.2 India Opioids Drug Revenue by Company (2016-2021)
11.2 India Opioids Drug Sales Breakdown by Type
11.2.1 India Opioids Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Opioids Drug Sales Breakdown by Type (2022-2027)
11.3 India Opioids Drug Sales Breakdown by Application
11.3.1 India Opioids Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Opioids Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Opioids Drug Business
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Business Overview
12.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Opioids Drug Products Offered
12.1.5 Teva Recent Development
12.2 Purdue Pharma
12.2.1 Purdue Pharma Corporation Information
12.2.2 Purdue Pharma Business Overview
12.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Purdue Pharma Opioids Drug Products Offered
12.2.5 Purdue Pharma Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Corporation Information
12.3.2 Mallinckrodt Business Overview
12.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mallinckrodt Opioids Drug Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Amneal Pharma
12.4.1 Amneal Pharma Corporation Information
12.4.2 Amneal Pharma Business Overview
12.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Amneal Pharma Opioids Drug Products Offered
12.4.5 Amneal Pharma Recent Development
12.5 Collegium
12.5.1 Collegium Corporation Information
12.5.2 Collegium Business Overview
12.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Collegium Opioids Drug Products Offered
12.5.5 Collegium Recent Development
12.6 J&J
12.6.1 J&J Corporation Information
12.6.2 J&J Business Overview
12.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 J&J Opioids Drug Products Offered
12.6.5 J&J Recent Development
12.7 Endo
12.7.1 Endo Corporation Information
12.7.2 Endo Business Overview
12.7.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Endo Opioids Drug Products Offered
12.7.5 Endo Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Business Overview
12.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Pfizer Opioids Drug Products Offered
12.8.5 Pfizer Recent Development
12.9 INSYS
12.9.1 INSYS Corporation Information
12.9.2 INSYS Business Overview
12.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 INSYS Opioids Drug Products Offered
12.9.5 INSYS Recent Development
12.10 Mylan
12.10.1 Mylan Corporation Information
12.10.2 Mylan Business Overview
12.10.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Mylan Opioids Drug Products Offered
12.10.5 Mylan Recent Development
12.11 Hikma
12.11.1 Hikma Corporation Information
12.11.2 Hikma Business Overview
12.11.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Hikma Opioids Drug Products Offered
12.11.5 Hikma Recent Development
12.12 Egalet
12.12.1 Egalet Corporation Information
12.12.2 Egalet Business Overview
12.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Egalet Opioids Drug Products Offered
12.12.5 Egalet Recent Development
13 Opioids Drug Manufacturing Cost Analysis
13.1 Opioids Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Opioids Drug
13.4 Opioids Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Opioids Drug Distributors List
14.3 Opioids Drug Customers
15 Market Dynamics
15.1 Opioids Drug Market Trends
15.2 Opioids Drug Drivers
15.3 Opioids Drug Market Challenges
15.4 Opioids Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Opioids Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Opioids Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Opioids Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Opioids Drug Sales (M Units) by Region (2016-2021)
Table 5. Global Opioids Drug Sales Market Share by Region (2016-2021)
Table 6. Global Opioids Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Opioids Drug Revenue Share by Region (2016-2021)
Table 8. Global Opioids Drug Sales (M Units) Forecast by Region (2022-2027)
Table 9. Global Opioids Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Opioids Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Opioids Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Opioids Drug Sales (M Units) of Key Companies (2016-2021)
Table 13. Global Opioids Drug Sales Share by Company (2016-2021)
Table 14. Global Opioids Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Opioids Drug Revenue Share by Company (2016-2021)
Table 16. Global Opioids Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids Drug as of 2020)
Table 17. Global Opioids Drug Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Opioids Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Opioids Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Opioids Drug Sales (M Units) by Type (2016-2021)
Table 22. Global Opioids Drug Sales Share by Type (2016-2021)
Table 23. Global Opioids Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Opioids Drug Price (USD/Unit) by Type (2016-2021)
Table 25. Global Opioids Drug Sales Share by Type (2022-2027)
Table 26. Global Opioids Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Opioids Drug Revenue Share by Type (2022-2027)
Table 28. Global Opioids Drug Price (USD/Unit) by Type (2022-2027)
Table 29. Global Opioids Drug Sales (M Units) by Application (2016-2021)
Table 30. Global Opioids Drug Sales Share by Application (2016-2021)
Table 31. Global Opioids Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Opioids Drug Price (USD/Unit) by Application (2016-2021)
Table 33. Global Opioids Drug Sales (M Units) by Application (2022-2027)
Table 34. Global Opioids Drug Sales Share by Application (2022-2027)
Table 35. Global Opioids Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Opioids Drug Revenue Share by Application (2022-2027)
Table 37. Global Opioids Drug Price (USD/Unit) by Application (2022-2027)
Table 38. North America Opioids Drug Sales (M Units) by Company (2016-2021)
Table 39. North America Opioids Drug Sales Market Share by Company (2016-2021)
Table 40. North America Opioids Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Opioids Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Opioids Drug Sales by Type (2016-2021) & (M Units)
Table 43. North America Opioids Drug Sales Market Share by Type (2016-2021)
Table 44. North America Opioids Drug Sales by Type (2022-2027) & (M Units)
Table 45. North America Opioids Drug Sales Market Share by Type (2022-2027)
Table 46. North America Opioids Drug Sales by Application (2016-2021) & (M Units)
Table 47. North America Opioids Drug Sales Market Share by Application (2016-2021)
Table 48. North America Opioids Drug Sales by Application (2022-2027) & (M Units)
Table 49. North America Opioids Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Opioids Drug Sales (M Units) by Company (2016-2021)
Table 51. Europe Opioids Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Opioids Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Opioids Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Opioids Drug Sales by Type (2016-2021) & (M Units)
Table 55. Europe Opioids Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Opioids Drug Sales by Type (2022-2027) & (M Units)
Table 57. Europe Opioids Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Opioids Drug Sales by Application (2016-2021) & (M Units)
Table 59. Europe Opioids Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Opioids Drug Sales by Application (2022-2027) & (M Units)
Table 61. Europe Opioids Drug Sales Market Share by Application (2022-2027)
Table 62. China Opioids Drug Sales (M Units) by Company (2016-2021)
Table 63. China Opioids Drug Sales Market Share by Company (2016-2021)
Table 64. China Opioids Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Opioids Drug Revenue Market Share by Company (2016-2021)
Table 66. China Opioids Drug Sales by Type (2016-2021) & (M Units)
Table 67. China Opioids Drug Sales Market Share by Type (2016-2021)
Table 68. China Opioids Drug Sales by Type (2022-2027) & (M Units)
Table 69. China Opioids Drug Sales Market Share by Type (2022-2027)
Table 70. China Opioids Drug Sales by Application (2016-2021) & (M Units)
Table 71. China Opioids Drug Sales Market Share by Application (2016-2021)
Table 72. China Opioids Drug Sales by Application (2022-2027) & (M Units)
Table 73. China Opioids Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Opioids Drug Sales (M Units) by Company (2016-2021)
Table 75. Japan Opioids Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Opioids Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Opioids Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Opioids Drug Sales by Type (2016-2021) & (M Units)
Table 79. Japan Opioids Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Opioids Drug Sales by Type (2022-2027) & (M Units)
Table 81. Japan Opioids Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Opioids Drug Sales by Application (2016-2021) & (M Units)
Table 83. Japan Opioids Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Opioids Drug Sales by Application (2022-2027) & (M Units)
Table 85. Japan Opioids Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Opioids Drug Sales (M Units) by Company (2016-2021)
Table 87. Southeast Asia Opioids Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Opioids Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Opioids Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Opioids Drug Sales by Type (2016-2021) & (M Units)
Table 91. Southeast Asia Opioids Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Opioids Drug Sales by Type (2022-2027) & (M Units)
Table 93. Southeast Asia Opioids Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Opioids Drug Sales by Application (2016-2021) & (M Units)
Table 95. Southeast Asia Opioids Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Opioids Drug Sales by Application (2022-2027) & (M Units)
Table 97. Southeast Asia Opioids Drug Sales Market Share by Application (2022-2027)
Table 98. India Opioids Drug Sales (M Units) by Company (2016-2021)
Table 99. India Opioids Drug Sales Market Share by Company (2016-2021)
Table 100. India Opioids Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Opioids Drug Revenue Market Share by Company (2016-2021)
Table 102. India Opioids Drug Sales by Type (2016-2021) & (M Units)
Table 103. India Opioids Drug Sales Market Share by Type (2016-2021)
Table 104. India Opioids Drug Sales by Type (2022-2027) & (M Units)
Table 105. India Opioids Drug Sales Market Share by Type (2022-2027)
Table 106. India Opioids Drug Sales by Application (2016-2021) & (M Units)
Table 107. India Opioids Drug Sales Market Share by Application (2016-2021)
Table 108. India Opioids Drug Sales by Application (2022-2027) & (M Units)
Table 109. India Opioids Drug Sales Market Share by Application (2022-2027)
Table 110. Teva Corporation Information
Table 111. Teva Description and Business Overview
Table 112. Teva Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Teva Opioids Drug Product
Table 114. Teva Recent Development
Table 115. Purdue Pharma Corporation Information
Table 116. Purdue Pharma Description and Business Overview
Table 117. Purdue Pharma Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Purdue Pharma Opioids Drug Product
Table 119. Purdue Pharma Recent Development
Table 120. Mallinckrodt Corporation Information
Table 121. Mallinckrodt Description and Business Overview
Table 122. Mallinckrodt Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Mallinckrodt Opioids Drug Product
Table 124. Mallinckrodt Recent Development
Table 125. Amneal Pharma Corporation Information
Table 126. Amneal Pharma Description and Business Overview
Table 127. Amneal Pharma Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Amneal Pharma Opioids Drug Product
Table 129. Amneal Pharma Recent Development
Table 130. Collegium Corporation Information
Table 131. Collegium Description and Business Overview
Table 132. Collegium Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Collegium Opioids Drug Product
Table 134. Collegium Recent Development
Table 135. J&J Corporation Information
Table 136. J&J Description and Business Overview
Table 137. J&J Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. J&J Opioids Drug Product
Table 139. J&J Recent Development
Table 140. Endo Corporation Information
Table 141. Endo Description and Business Overview
Table 142. Endo Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Endo Opioids Drug Product
Table 144. Endo Recent Development
Table 145. Pfizer Corporation Information
Table 146. Pfizer Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Pfizer Description and Business Overview
Table 148. Pfizer Opioids Drug Product
Table 149. Pfizer Recent Development
Table 150. INSYS Corporation Information
Table 151. INSYS Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. INSYS Description and Business Overview
Table 153. INSYS Opioids Drug Product
Table 154. INSYS Recent Development
Table 155. Mylan Corporation Information
Table 156. Mylan Description and Business Overview
Table 157. Mylan Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Mylan Opioids Drug Product
Table 159. Mylan Recent Development
Table 160. Hikma Corporation Information
Table 161. Hikma Description and Business Overview
Table 162. Hikma Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Hikma Opioids Drug Product
Table 164. Hikma Recent Development
Table 165. Egalet Corporation Information
Table 166. Egalet Description and Business Overview
Table 167. Egalet Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Egalet Opioids Drug Product
Table 169. Egalet Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Opioids Drug Distributors List
Table 173. Opioids Drug Customers List
Table 174. Opioids Drug Market Trends
Table 175. Opioids Drug Market Drivers
Table 176. Opioids Drug Market Challenges
Table 177. Opioids Drug Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Drug Product Picture
Figure 2. Global Opioids Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Opioids Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Pain Relief Examples
Figure 7. Anesthesia Examples
Figure 8. Others Examples
Figure 9. Global Opioids Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Opioids Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Opioids Drug Sales (M Units) Growth Rate (2016-2027)
Figure 12. Global Opioids Drug Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Opioids Drug Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Opioids Drug Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Opioids Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Opioids Drug Sales (M Units) Growth Rate (2016-2027)
Figure 17. Europe Opioids Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Opioids Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Opioids Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Opioids Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Opioids Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Opioids Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Opioids Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Opioids Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Opioids Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Opioids Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Opioids Drug Players Market Share by Revenue in Opioids Drug: 2016 & 2020
Figure 28. Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Opioids Drug Revenue Share by Type (2016-2021)
Figure 30. Global Opioids Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Opioids Drug Revenue Share by Application (2016-2021)
Figure 32. Global Opioids Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Opioids Drug Sales Market Share by Type in 2020
Figure 34. North America Opioids Drug Sales Market Share by Application in 2020
Figure 35. Europe Opioids Drug Sales Market Share by Type in 2020
Figure 36. Europe Opioids Drug Sales Market Share by Application in 2020
Figure 37. China Opioids Drug Sales Market Share by Type in 2020
Figure 38. China Opioids Drug Sales Market Share by Application in 2020
Figure 39. Japan Opioids Drug Sales Market Share by Type in 2020
Figure 40. Japan Opioids Drug Sales Market Share by Application in 2020
Figure 41. Southeast Asia Opioids Drug Sales Market Share by Type in 2020
Figure 42. Southeast Asia Opioids Drug Sales Market Share by Application in 2020
Figure 43. India Opioids Drug Sales Market Share by Type in 2020
Figure 44. India Opioids Drug Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Opioids Drug
Figure 47. Manufacturing Process Analysis of Opioids Drug
Figure 48. Opioids Drug Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
オピオイド薬のグローバル市場調査 2019年 The global Opioids Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Opioids Drugs volume and value at global level, regional level and company level. From a global perspective, this report repr…- 世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
- 世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年） Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Market Analysis and Insights: Global Ambrisentan Drug Market The global Ambrisentan Drug market size is projected to reach …
- 世界の甲状腺機能低下症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypothyroidism Drug Market The global Hypothyroidism Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
- ナルコレプシー治療薬のグローバル市場2021 Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss o…